Sedana Medical AB (publ) (FRA:7D2A)

Sedana Medical AB Statistics

Total Valuation

FRA:7D2A has a market cap or net worth of EUR 88.84 million. The enterprise value is 80.76 million.

Market Cap	88.84M
Enterprise Value	80.76M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	99.34M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	65.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.80
PB Ratio	1.07
P/TBV Ratio	1.10
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-14.75
EV / Sales	4.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-57.57

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.01.

Current Ratio	3.40
Quick Ratio	2.58
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-9.71

Financial Efficiency

Return on equity (ROE) is -6.37% and return on invested capital (ROIC) is -2.19%.

Return on Equity (ROE)	-6.37%
Return on Assets (ROA)	-2.08%
Return on Invested Capital (ROIC)	-2.19%
Return on Capital Employed (ROCE)	-3.63%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	151,651
Profits Per Employee	-44,871
Employee Count	122
Asset Turnover	0.20
Inventory Turnover	1.38

Taxes

In the past 12 months, FRA:7D2A has paid 182,958 in taxes.

Income Tax	182,958
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-46.22%
50-Day Moving Average	0.90
200-Day Moving Average	1.04
Relative Strength Index (RSI)	45.98
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:7D2A had revenue of EUR 18.50 million and -5.47 million in losses. Loss per share was -0.06.

Revenue	18.50M
Gross Profit	13.19M
Operating Income	-3.03M
Pretax Income	-5.29M
Net Income	-5.47M
EBITDA	-995,641
EBIT	-3.03M
Loss Per Share	-0.06

Balance Sheet

The company has 8.41 million in cash and 434,016 in debt, with a net cash position of 7.97 million.

Cash & Cash Equivalents	8.41M
Total Debt	434,016
Net Cash	7.97M
Net Cash Per Share	n/a
Equity (Book Value)	83.23M
Book Value Per Share	0.84
Working Capital	11.34M

Cash Flow

In the last 12 months, operating cash flow was -1.18 million and capital expenditures -222,136, giving a free cash flow of -1.40 million.

Operating Cash Flow	-1.18M
Capital Expenditures	-222,136
Free Cash Flow	-1.40M
FCF Per Share	n/a

Margins

Gross margin is 71.27%, with operating and profit margins of -16.39% and -29.59%.

Gross Margin	71.27%
Operating Margin	-16.39%
Pretax Margin	-28.60%
Profit Margin	-29.59%
EBITDA Margin	-5.38%
EBIT Margin	-16.39%
FCF Margin	n/a

Dividends & Yields

FRA:7D2A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.16%
FCF Yield	-1.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 26, 2021. It was a forward split with a ratio of 4.

Last Split Date	May 26, 2021
Split Type	Forward
Split Ratio	4

Scores

FRA:7D2A has an Altman Z-Score of 14.21 and a Piotroski F-Score of 3.

Altman Z-Score	14.21
Piotroski F-Score	3